Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

INTUITIVE SURGICAL, INC.

(ISRG)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Intuitive Surgical : Morgan Stanley Adjusts Price Target on Intuitive Surgical to $325 from $310, Keeps Equalweight Rating

10/21/2021 | 01:06pm EST


ę MT Newswires 2021
All news about INTUITIVE SURGICAL, INC.
01/12Intuitive Surgical Sees 17% Rise in Q4 Revenue
MT
01/12Intuitive Surgical Sees 4Q Revenue Topping Street Views
DJ
01/12INTUITIVE SURGICAL : ANNOUNCES PRELIMINARY FOURTH QUARTER AND FULL YEAR 2021 RESULTS - For..
PU
01/12INTUITIVE SURGICAL INC : Results of Operations and Financial Condition (form 8-K)
AQ
01/12Intuitive Announces Preliminary Fourth Quarter and Full Year 2021 Results
AQ
01/11NORTH AMERICAN MORNING BRIEFING : Inflation, Rate -3-
DJ
01/10BTIG Upgrades Intuitive Surgical to Buy from Neutral, Sets $372 Price Target
MT
2021Intuitive Surgical Says US FDA Approves SureForm 30 Stapler for Surgical Use
MT
2021Intuitive receives FDA clearance for 8 mm SureForm 30 Curved-Tip Stapler
AQ
2021Intuitive Receives FDA Clearance for 8 mm SureForm 30 Curved-Tip Stapler
CI
More news
Analyst Recommendations on INTUITIVE SURGICAL, INC.
More recommendations
Financials (USD)
Sales 2021 5 721 M - -
Net income 2021 1 668 M - -
Net cash 2021 2 405 M - -
P/E ratio 2021 64,7x
Yield 2021 -
Capitalization 110 B 110 B -
EV / Sales 2021 18,8x
EV / Sales 2022 16,4x
Nbr of Employees 8 081
Free-Float -
Chart INTUITIVE SURGICAL, INC.
Duration : Period :
Intuitive Surgical, Inc. Technical Analysis Chart | ISRG | US46120E6023 | MarketScreener
Technical analysis trends INTUITIVE SURGICAL, INC.
Short TermMid-TermLong Term
TrendsBearishBearishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 18
Last Close Price 307,74 $
Average target price 354,93 $
Spread / Average Target 15,3%
EPS Revisions
Managers and Directors
Gary S. Guthart President, Chief Executive Officer & Director
Calvin Darling Senior Director-Finance & Investor Relations
Jamie E. Samath Chief Financial Officer
Craig H. Barratt Chairman
Myriam J. Curet Chief Medical Officer & Executive Vice President
Sector and Competitors